UiPath Q4 2026 Earnings Breakdown: Agentic AI Powers Profits But Growth Hits a Speed Bump

#Q4 Fiscal 2026: Beating Expectations but with Nuanced Signals

In the fourth quarter, UiPath posted revenue of $481 million, marking a 14% increase year-over-year and surpassing analyst estimates of around $465 million. This beat is noteworthy, especially as it follows a Q3 revenue of $411 million, which grew 16% YoY, indicating some sequential acceleration in absolute terms but a slight slowdown in percentage growth.

ARR reached $1.853 billion, up 11% from the previous year, with net new ARR contributing $70 million. Compared to Q3's $1.782 billion ARR and $59 million net new, this shows consistent addition, but the 11% growth rate has held steady, raising questions about whether UiPath can reignite faster expansion amid intensifying competition from players like Microsoft.

Profitability metrics shine brightly: GAAP operating income at $80 million flips from prior losses, and non-GAAP at $150 million reflects robust margins. Cash flows are equally impressive, with $182 million from operations and adjusted free cash flow, bolstering a cash pile of $1.69 billion. This cash generation is a game-changer, transforming UiPath from a cash-burning growth story to a self-sustaining entity, which is rare in AI and gives them ammunition for strategic moves without tapping markets.

Gross margins stood at 85% GAAP and 86% non-GAAP, consistent with efficiency gains. The dollar-based net retention rate of 107% implies customers are modestly expanding, but at just 7% average uplift, it's underwhelming for a platform touting AI scalability. In my view, this metric screams opportunity—if UiPath can boost upsells through agentic features, it could turbocharge future ARR.

1. Customer Base Details

   Total customers at approximately 10,750, with 2,565 spending $100k+ in ARR, highlighting a focus on enterprise wins where the real money lies.

2. Average ARR per Customer

   Roughly $172,000 overall, but skewed higher for large accounts, suggesting a long tail of smaller users that could be ripe for upgrades or a drag if churn rises.

The net new ARR of $70 million, while solid, represents about 4% of total ARR, a figure that pales against historical hyper-growth phases where additions were more aggressive. This consistency is admirable in a cautious macro, but it hints at maturation rather than explosion, which might disappoint growth-oriented investors.

#Full Year Fiscal 2026: Profitability Milestone Amid Slowing Momentum

For the full year, revenue climbed to $1.611 billion, a 13% rise from fiscal 2025's $1.43 billion. This continues a trend of decelerating growth: from 23.6% in FY2024 (to $1.308B), 18.6% in FY2023 (to $1.059B), and even higher in earlier years like 46% from FY2021's $608 million to FY2022's $892 million.

Net new ARR totaled $186 million, supporting the 11% ARR growth to $1.853 billion. GAAP operating income of $57 million marks the first profitable year on this basis, with non-GAAP at $370 million. Cash flows hit $371 million operating and $372 million free, underscoring discipline. Hitting GAAP profitability is a badge of honor, signaling UiPath has tamed its cost structure, but the growth slowdown from 20%+ historically to low teens feels like shifting from sprint to jog—sustainable, yes, but is it enough in AI's gold rush?

The stock repurchase story adds flavor: Completing $1 billion in buybacks and authorizing another $500 million screams undervaluation to me. With shares trading around $12 pre-earnings, down 29% in three months but up 5% annually, management is betting on a rebound. This move could tighten supply and boost EPS, a clever capital allocation in volatile times. UiPath's historical revenue growth the past few years looks like the following:

1. FY 2026

   +13% to $1.611B

2. FY 2025

   +9.3% to $1.43B

3. FY 2024

   +23.6% to $1.308B

4. FY 2023

   +18.6% to $1.059B

5. FY 2022

   +46% to $892M

Digging deeper, the average ARR growth over the last two years at 13.2% lags the five-year trend, per analyst notes. This deceleration, coupled with Q3's 10.9% ARR growth, suggests external pressures like competition or market saturation are at play.

#What UiPath is Crushing: AI Innovation and Financial Fortitude

UiPath's agentic AI pivot is spot-on, blending automation with AI for complex processes. The WorkFusion acquisition enhances financial crime compliance, potentially adding high-margin revenue in banking. This move is brilliant—compliance is sticky and recession-resistant, positioning UiPath as indispensable in regulated sectors.

Partnerships with Talkdesk and Veeva deepen industry penetration, while accolades like Forrester Leader status and OSWorld top ranking validate tech superiority. The AIUC-1 certification? That's a trust builder in security-paranoid enterprises. Financially, $372 million free cash flow equips them for growth without dilution, a stark contrast to cash-hungry peers.

Humor aside, UiPath automating its own profitability is meta and effective. The 11% ARR growth, though modest, outpaces FY2025's 9.3% revenue uptick, showing subscription strength. With 10,750 customers, up from prior years (e.g., 7,968 in 2021), scale is evident, and the 2,565 large accounts (likely growing faster) indicate enterprise traction.

1. Healthcare Innovations

   Agentic solutions for claims and authorizations could capture billions in efficiency, a massive TAM where UiPath's governance shines.

2. Benchmark Wins

   No. 1 on OSWorld signals real-world efficacy, potentially swaying CIOs from competitors.

UiPath's resilience in a slowing market is underrated. While others chase hype, their focus on governed AI gives a defensible moat, and that 107% retention, though not elite, beats churn nightmares elsewhere.

#Where UiPath Falters: Growth Deceleration and Competitive Pressures

The 11% ARR growth lags historical highs (e.g., 65% revenue growth in 2020), hinting at maturity or headwinds. Net retention at 107% is decent but far from the 120%+ that screams product-market fit nirvana. This stagnation in expansion metrics suggests customers aren't scaling as fast as hoped, perhaps due to AI complexity or budget scrutiny.

Guidance raises red flags: Q1 2027 revenue $395-400 million implies a 17% sequential drop from Q4, though up slightly from Q3's $411 million—seasonality, sure, but it spotlights deal lumpiness. FY2027 ARR $2.051-2.056 billion forecasts another 11% growth, with revenue up 9% to ~$1.756 billion. In AI's boom, this feels tepid; investors crave 20%+.

The GAAP-non-GAAP gap ($57M vs. $370M) underscores heavy stock comp, diluting value. Competition from Microsoft et al. threatens, and joining AAIF is defensive but risks commoditization. Average billings growth of 2.3% last year per reports? That's alarming, indicating hesitancy in commitments.

UiPath's growth engine is sputtering compared to its explosive past. With ARR per customer at $172k but many below $100k, churn in SMBs could bite, and the enterprise focus, while smart, needs faster wins to offset.

#Market Reaction: A Dip Despite the Beat

Post-earnings, PATH shares dipped over 5% after-hours from a close of $12.38, despite beating revenue ($481M vs. $465M est.) and EPS estimates. Social buzz highlighted beat history but focused on soft guidance.

Analyst targets median $17, suggesting upside potential. The initial dip is likely an overreaction; with buybacks and cash, UiPath looks undervalued, but the market's punishing the lack of growth acceleration, a common AI stock fate.

#Looking Forward: Steady Ship or Missed Opportunity?

Guidance points to reliable progress: 9% revenue growth, 11% ARR to $2.054 billion, non-GAAP income $415 million. Acquisitions and partnerships could juice this, but risks like slowdowns or regs loom.

UiPath is the dependable automation stalwart, finally profitable and cashed up, but in AI's wild west, reliability might not cut it. If agentic AI in healthcare and finance explodes, upside abounds—watch for retention climbs and net new ARR spikes. That stock dip? A buying chance for patient investors betting on execution over flash. Yet, without growth reacceleration, it risks being a value trap. In sum, solid but not spectacular; a sleeper if they nail the AI wave.